2023 ASCCP Scientific Meeting Program

Pre-Course: Vulvovaginal Didactic

Course Director: Hope K. Haefner, MD

Faculty: EJ Mayeux, Jr., MD
Colleen Stockdale, MD, MS
Kathryn C. Welch, MD

8:00 - 9:00am
Difficult Conditions or Situations

9:00 - 9:30am
Update on Vaginitis

9:30 - 10:00am
Operations for Introital Dyspareunia and Apareunia

10:00 - 10:15am
Questions and Answers

10:15 - 10:30am
Break

10:30 - 11:05am
Your Diagnosis Is? Test Your Knowledge of Various Vulvovaginal Conditions

11:05 - 11:45am
What’s New in Vulvovaginal Disease

11:45 - 12:00pm
Questions and Answers

Pre-Course: Mini COMP Course

Course Director: Michael Gold, MD

Faculty: Richard Guido, MD
Alan G. Waxman, MD, MPH

8:00 - 8:30am
Didactic Presentation

8:30 - 9:00am
Didactic Presentation

9:00 - 9:30am
Case presentation

9:30 - 9:45am
Q&A

9:45 - 10:00am
Break

10:00 - 12:00pm
Breakout sessions—40 minutes each

A. Where to biopsy images
B. Colpo procedure
C. LEEP

Pre-Course: Vulvar Surgery Skills Workshop – Basic

Course Director: E.J. Mayeaux, Jr., MD

Faculty: Colleen Stockdale, MD, MS

1:00 - 1:10pm
Welcome and Opening Remarks

1:10-3:15pm
Hands-On Workshops

• Biopsy Techniques
• Sutures/Laying out the Excision, & Closure Techniques

3:15-3:30pm
Break

3:30-5:00
Hands-On Workshops (Continued)

Pre-Course: Vulvar Surgery Skills Workshop – Advanced

Course Director: Hope K. Haefner, MD

Faculty: Michael Fitzsimmons, MD
Kathryn C. Welch, MD

1:00 - 1:10pm
Welcome and Opening Remarks

1:10 - 3:15pm
Hands-On Workshops

• Excisions/Laying out the Excision & Closure Techniques
• Office and Operating Room Procedures
• Flaps and Grafts
• O-to-Z Plasty, V-Y and Double V-Y Plasty, Vestibulectomy, Rotation Flap, Full Thickness Skin Grafts, Split Thickness Skin Grafts

3:15 - 3:30pm
Break

3:30 - 5:00pm
Hands-On Workshops (Continued)

Moderator: Levi Downs, Jr., MD, MS

Assess the pros and cons of cervical cancer screening in patients under 25 years of age and those older than 65 years of age. Experts will debate the merits of screening in these populations.

Patti Gravitt, PhD,
E.J. Mayeaux, MD
Anna-Barbara Moscicki, MD
Debbie Saslow, PhD

Back to Basics Track

Determine the essential steps to start a colposcopy practice with perspectives from both a physician and a nurse practitioner.

Michael Gold, MD
Carolann Risley, NP, PhD

Screening and Prevention Track

Learn the latest updates to cervical cancer screening guidelines and how they continue to evolve with new research and technology.

Mark Einstein, MD, MS

Oral Abstracts

The value of Internet-based HPV self-sampling for increasing coverage of cervical cancer screening
Jingran Li, MD

Implications of primary high-risk (hrHPV) cervical cancer screening for hrHPV-negative patients with cervical dysplasia
Padmini Manrai, MD

Colposcopy follow-up and findings among pregnant patients
Joann Gold, MD

Management and Treatment Track

Identify a mixture of benign and malignant lesions of the vulva and vagina that are seen in practice, through a case-based approach.

E.J. Mayeaux, Jr., MD

Oral Abstracts

Clinical performance of a urine-based assay for the detection of HPV and CIN
Yun Zhao, MD, PhD

US Trends of Vulvovaginal Melanoma: A Silent Increase Despite Improvements in Cervical Cancer Incidence Rates
Chapman Wei, MD

Incidence of VaIN on surveillance cytology in patients with previous hysterectomy for CIN3+:A population-based study
Sabrina Piedimonte, MDCM, MSc,FRCSC

Satellite Symposium Lunch

Global Cervical Cancer Control: Will We Ever Get That Rock To The Top Of The Hill?
Through an exploration of the critical gaps in the global strategy for cervical cancer control, discover why the WHO goal of global cervical cancer control in the 21st century is unlikely to be realized without the rapid implementation of a comprehensive strategy.

Philip Castle, PhD, MPH

Advancing Prevention Clinical Research on Cervical Cancer and HPV-related Cancers
Explore NCI’s programs on prevention through clinical research on cervical cancer and HPV-related cancers in both low- and middle-income countries as well as in settings of healthcare disparities in the United States. Including the NCI Cervical Cancer ‘Last Mile’ Initiative, ULACNet, and the ‘CASCADE’ Clinical Trials Network.

Vikrant Sahasrabuddhe, MPH, MBBS, DrPH

Top Oral Abstracts

Cervical meta-omic analyses identify tyramine metabolism in women with dysplasia
Josefina Romaguera, MD, MPH, FACOG

Novel self-sampling device for HPV and Pap cytology to increase cervical cancer (CC) screening access and adherence
LaShonda Crane, DNP

Back to Basics Track

Follow clinical scenarios step-by-step through ASCCP’s Management Guidelines App and learn its full functionality.

Akiva Novetsky, MD, MS
Peter Schnatz, DO

Screening and Prevention Track

Review the epidemiology of anal cancer, different modalities for anal cancer screening, and treatment options for anal intraepithelial neoplasia.

Huma Farid, MD
Eric Ganz, MD
Sara McKinney, MD

Oral Abstracts

Anal High-grade Squamous Intraepithelial Lesions (HSIL) in Women Living with HIV (WLHIV) 2 Year Outcomes
Elizabeth Stier, MD

Trends in Women’s Anogenital Cancers: The Kaiser Women’s Anal Cancer Study
Michelle Khan, MD, MPH

Complementary and Alternative Medications for HPV Infections
Caroline Walsh

Management and Treatment Track

Learn how new technologies, such as dual staining and extended genotyping, are assessed for inclusion in the cervical cancer management guidelines.

Francisco Garcia, MD, MPH
Nicolas Wentzensen, MD, PhD

Oral Abstracts

Clinical Outcomes Of Women who attend the Cameroon Baptist Convention Health Services (CBCHS) With Cervical Cancer
Ngalla Calvin, BSN, MS

Colposcopy clinic standard operating procedures’ effect on timely follow-up and colposcopy adherence
Rita Sartor, MD

Evaluation of regression rates of CIN II/III and appropriate rescreening interval in the Hispanic population
Mostafa Eyada, MD

Moderator: Lisa Flowers, MD, MPH

Should people ages 27-45 undergo vaccination for HPV? Experts debate the merit of vaccination to mitigate possible disease risk in this age group and inclusive of healthcare workers treating HPV-associated conditions.

Richard Guido, MD
Michelle Khan, MD, MPH

Trainee Research Award Winner: Will integrating HPV-based cervical cancer screening with visits for early childhood vaccinations increase uptake and cost-effectiveness in Kampala, Uganda?
Megan Swanson, MD

Sex Steroid Hormone Impact on Postpartum HPV Vaccination (SSHiP) Study
Megan Lander, MD

Top Oral Abstracts—Part 2

Evaluation of AI-enabled cytology for triaging HPV-positive women: A population-based perspective study
Peng Xue, PhD, MPH

Cervical cancer prevention training program in Mozambique for Obstetrics & Gynecology residents
Mila Salcedo, MD, PhD

Back to Basics Track

Learn how to integrate diversity, equity, and inclusion (DEI) into your practice to foster a more inclusive environment and improve care for patients in the field of colposcopy.

Michelle Khan, MD, MPH
Lindsey Kuroki, MD, MSCI
Michael Pirics, MD

Screening and Prevention Track

Transition to Primary HPV Screening
Review the evidence behind screening methodology and the progress made thus far towards the transition to primary HPV screening.

Debbie Saslow, PhD

HPV Self-Collection Study & Results
Review the results of a focus group study of frontline healthcare providers regarding HPV self-collection as a tool to increase cervical cancer screening rates.

Jacqueline Bohn, MD

Management and Treatment Track

Hear about the updated guidance for cervical cancer screening in immunocompromised patients along with a new screening recommendation from CDC for women with HIV.

Lisa Flowers, MD, MPH

Oral Abstracts

Diagnostic Accuracy of HPV DNA Full Genotyping and Risk-based Strategy in Cervical Cancer Screening
Xiao Li, MD

Perianal Warts in HIV-infected MSM: A Non-negligible Risk of Precancer and Cancer
Yuxin Liu, MD, PhD

Immediate cone biopsy in the office for patients with high-grade squamous intraepithelial lesion (HSIL) in Colombia
Sonia Salamanca Mora, MD

Moderator:Levi Downs, MD, MS

ECC
Review updated guidelines for performing endocervical curettage (ECC) among patients referred to colposcopy for abnormal cervical cancer screening tests.

Michael Gold, MD
L. Stewart Massad, Jr., MD

Updates on HPV Vaccination: Global and Local Perspectives
Learn more about the efficacy and potential public health impact of a single-dose HPV vaccination strategy based on data from the Costa Rica HPV Vaccine Trial.

Aimée R. Kreimer, PhD

Back to Basics Track

Discuss barriers to communication with patients and learn specific strategies to build rapport and address patient questions and concerns specific to HPV.

Christine Conageski, MD
Amy Wiser, MD

Screening and Prevention Track

Assess the issues that prevail in certain US states that have low vaccination rates but high cervical cancer mortality rates.

Nancy Phillips, MD
Riddhimaa Sinha

Oral Abstracts

The significance of human papillomavirus receptors related genetic variants in cervical cancer screening
Hongyu Xie

Perceived barriers and use of evidence-based practices for adolescent HPV vaccination among East Texas providers
Lindy McGee, MD

Recommendation of HPV vaccination among providers involved in cervical cancer prevention activities in Africa
Joel Fokum Domingue, MD, MPH

Management and Treatment Track

Learn about the challenges faced by providers and patients along the Texas–Mexico border that prevent uninsured women from accessing care and how these challenges are being addressed.

Mila Salcedo, MD, PhD

Oral Abstracts

Underdiagnosis of CIN2 by colposcopy is associated with thin HSILs-an supportive evidence for ASCCP Colposcopy Standards
Mingzhu Li, MD, PhD

Retrospective Cohort Study to assess the effect on Colposcopy of a multicomponent program in Texas' Rio Grande Valley
Melissa Lopez Varon, PhD, MSc

Barriers to Cervical Cancer Screening: Results from a State Comprehensive Cancer Control Coalition Survey
Susan Parker, MPH

Moderator: David Chelmow, MD

Review the evidence and educational modules in development regarding epidemiology, screening, diagnosis, and disparities in lower anogenital tract (vaginal, vulvar, and anal) cancers.

Helen Cejtin, MD
Christine Conageski, MD
Huma Fardi, MD

Moderator: Michelle Khan, MD, MPH

Discover the results of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer and to identify biomarkers of progression.

Joel Palefsky, MD